Where is JAZZ Pharma located in the US?
Jazz Pharmaceuticals maintains its primary United States operational headquarters and corporate offices in Palo Alto, California, situated right in the heart of the Silicon Valley biotechnology corridor. Additionally, the biopharmaceutical enterprise operates major regional hubs, clinical research facilities, and administrative offices in other key American life science centers, including Philadelphia, Pennsylvania, allowing close coordination of its nationwide clinical development programs and commercial drug distribution networks.
Related FAQs
JBS S.A. distributes regular dividend payments to its eligible shareholders, operating as a massive publicly traded food processing multinational enterprise.
Senior directors overseeing commercial real estate brokerage, corporate solutions, property asset management, or capital markets divisions at Jones Lang LaSalle (JLL) earn lucrative professional packages combining competitive base compensation with p...
Jazz Pharmaceuticals plc (JAZZ) is a global biopharmaceutical enterprise focused on developing life-changing medicines for people with serious neurological and oncological conditions, including flagship sleep medicine and neuroscience treatments.
Jazz Pharmaceuticals operates in the biopharmaceutical sector focusing on neuroscience and oncology therapeutics, carrying typical clinical and commercial risks.
Oxycodone is a potent opioid analgesic manufactured and distributed by numerous generic and brand-name pharmaceutical companies worldwide.
Jazz Pharmaceuticals plc, a global biopharmaceutical enterprise dedicated to developing life-changing medicines for people with serious diseases—particularly within neuroscience and oncology—has its global corporate headquarters located in Dublin, Ir...
Lipitor (atorvastatin), manufactured by Pfizer, holds the historical record for generating the highest cumulative sales volume of any pharmaceutical drug ever commercialized.
Jazz Pharmaceuticals operates as a consistently profitable biopharmaceutical enterprise, generating substantial revenues from its commercialized medical portfolio targeting complex neurological and oncological conditions.
Jazz Pharmaceuticals is a prominent global biopharmaceutical company focusing heavily on neuroscience therapeutics, sleep medicine, and innovative oncology treatments.
Jazz Pharmaceuticals anticipates an evolving future outlook shaped by the ongoing commercialization of its core neuroscience and oncology franchises, alongside strategic pipeline expansions into next-generation multispecific antibodies.
Jazz Pharmaceuticals is frequently evaluated favorably by Wall Street equity analysts, holding a strong consensus buy rating supported by its diverse portfolio of specialized therapeutics and robust product pipeline.
Jazz Pharmaceuticals is widely regarded as a strong and reputable biopharmaceutical firm specializing in developing and commercializing life-changing medicines for people with serious and complex diseases, particularly in the therapeutic areas of neu...
Jazz Pharmaceuticals operates as a consistently profitable enterprise, generating substantial commercial revenues from its specialized drug portfolio that successfully offset ongoing research and development expenses.
Kaleida Health operates with a comprehensive healthcare workforce comprising approximately eight thousand six hundred forty-six employees, functioning as the largest healthcare provider system in Western New York.
Jazz Pharmaceuticals did not originate as a traditional legacy corporate entity with a single prior consumer-facing name, but rather was founded as a specialty biopharmaceutical company that expanded rapidly through strategic corporate acquisitions, ...